Bombay High Court allows Bharat Biotech to use a plant in Poona to scale up Covaxin production, directs Maharashtra to grant requisite approvals

The manufacturing facility owned by Intervet India Pvt Ltd was in the process of shutting down for commercial reasons when Bharat Biotech came forward to use the facility with permission from Intervet.
Bombay High Court allows Bharat Biotech to use a plant in Poona to scale up Covaxin production, directs Maharashtra to grant requisite approvals
Covaxin, Bharat Biotech

The Bombay High Court on Thursday permitted Biovet Pvt. Ltd., an associate company of Bharat Biotech to take possession of the 'ready to use' manufacturing plant in Pune, Maharashtra to operate and manufacture COVID-19 vaccine, 'Covaxin'

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com